{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T18:12:32Z","timestamp":1771006352631,"version":"3.50.1"},"reference-count":31,"publisher":"Begell House","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Environ Pathol Toxicol Oncol"],"published-print":{"date-parts":[[2026]]},"abstract":"<p>Recent research highlights the pivotal function of long non-coding RNAs (lncRNAs) in bladder cancer (BCa) progression, emphasizing the need to understand their functions. The clinical significance and molecular mechanisms of lncRNA FENDRR in BCa needed to be elucidated. The Gene Expression Omnibus (GEO) database for BCa-related lncRNAs was screened. Tumor and para cancerous tissues from 118 patients with BCa were collected. Real-time quantitative polymerase chain reaction assessed FENDRR, microRNA (miR)-18a-5p, and estrogen receptor 1 (ESR1) levels. Kaplan-Meier curves assessed FENDRR's prognostic significance. Cell Counting Kit-8, Transwell, and flow cytometry evaluated cell proliferation, migration, invasion, and apoptosis. Dual-Luciferase Reporter and RNA Immunoprecipitation assays revealed miR-18a-5p targeting of FENDRR and ESR1. FENDRR exhibited differential expression in BCa GEO databases. Notably, FENDRR and ESR1 were downregulated, while miR-18a-5p was upregulated in BCa tissues and cell lines. Low FENDRR expression correlated with poor clinical prognosis. Upregulating FENDRR hindered cell proliferation, migration, and invasion while promoting apoptosis; however, miR-18a-5p reversed this suppression. Mechanistically, miR-18a-5p directly targets both FENDRR and ESR1. Our study reveals that low FENDRR expression is a poor prognostic indicator in BCa. FENDRR inhibits miR-18a-5p to upregulate ESR1 and hinder cancer progression, suggesting potential therapeutic targets.<\/p>","DOI":"10.1615\/jenvironpatholtoxicoloncol.2025056717","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T21:05:56Z","timestamp":1752786356000},"page":"1-12","source":"Crossref","is-referenced-by-count":0,"title":["lncRNA FENDRR as a Prognostic Biomarker and Regulator of Bladder Cancer Progression via the miR-18a-5p\/ESR1 Axis"],"prefix":"10.1615","volume":"45","author":[{"given":"Chao","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiliang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Lou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"613","reference":[{"key":"2","doi-asserted-by":"crossref","unstructured":"Li F, Zhang H, Huang Y, Li D, Zheng Z, Xie K, Cao C, Wang Q, Zhao X, Huang Z, Chen S, Chen H, Fan Q, Deng F, Hou L, Deng X, Tan W. Single-cell transcriptome analysis reveals the association between histone lactylation and cisplatin resistance in bladder cancer. Drug Resist Updat. 2024;73:101059.","DOI":"10.1016\/j.drup.2024.101059"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Li WJ, Li G, Liu ZW, Chen ZY, Pu R. lncRNA LINC00355 promotes EMT and metastasis of bladder cancer cells through the miR-424-5p\/HMGA2 axis. Neoplasma. 2021;68(6):1225-35.","DOI":"10.4149\/neo_2021_210427N574"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Zhao Q, Xiong S, Cai H, He X, Shi X. Expression and significance of the long non-coding RNA APTR in the occurrence and development of lung adenocarcinoma. J Environ Pathol Toxicol Oncol. 2025;44(1):11-20.","DOI":"10.1615\/JEnvironPatholToxicolOncol.2024053394"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Chen Z, Liu S, Wang J, Chen Y. The long non-coding RNA SNHG1 predicts severity of acute pancreatitis and stimulates pancreatic cell apoptosis and inflammatory response. J Environ Pathol Toxicol Oncol. 2024;43(4):81-93.","DOI":"10.1615\/JEnvironPatholToxicolOncol.2024053229"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Dai G, Huang C, Yang J, Jin L, Fu K, Yuan F, Zhu J, Xue B. lncRNA SNHG3 promotes bladder cancer proliferation and metastasis through miR-515-5p\/GINS2 axis. J Cell Mol Med. 2020;24(16):9231-43.","DOI":"10.1111\/jcmm.15564"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Zhou J, Xu J, Cheng L, Li S, Jiang D, Zhang J, Sheng Y. Alteration of lncRNA RHPN1-AS1 predicts clinical prognosis and regulates the progression of bladder cancer via modulating miR-485-5p. Int J Biol Markers. 2024;39(4):284-91.","DOI":"10.1177\/03936155241281076"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Niu C, Tan S. lncRNA FENDRR suppresses melanoma growth via influencing c-Myc mRNA level. Clin Cosmet Investig Dermatol. 2023;16:2119-28.","DOI":"10.2147\/CCID.S409622"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Yang J, Hu Y, Tan Z, Zhang F, Huang W, Chen K. The lncRNA FENDRR inhibits colorectal cancer progression via interacting with and triggering GSTP1 ubiquitination by FBX8. Heliyon. 2023;9(12):e23161.","DOI":"10.1016\/j.heliyon.2023.e23161"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Herrera-Merchan A, Cuadros M, Rodriguez MI, Rodriguez S, Torres R, Estecio M, Coira IF, Loidi C, Saiz M, Carmona-Saez P, Medina PP. The value of lncRNA FENDRR and FOXF1 as a prognostic factor for survival of lung adenocarcinoma. Oncotarget. 2020;11(13):1172-85.","DOI":"10.18632\/oncotarget.22154"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Li S, Li B, Zheng Y, Li M, Shi L, Pu X. Exploring functions of long noncoding RNAs across multiple cancers through co-expression network. Sci Rep. 2017;7(1):754.","DOI":"10.1038\/s41598-017-00856-8"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Yin SL, Xiao F, Liu YF, Chen H, Guo GC. Long non-coding RNA FENDRR restrains the aggressiveness of CRC via regulating miR-18a-5p\/ING4 axis. J Cell Biochem. 2020;121(8-9):3973-85.","DOI":"10.1002\/jcb.29555"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Zhang Z, Liu T, Cheng C, Wang J, Wang C, Huang H, Li Y. lncRNA GAS5 regulates the Wnt\/beta-catenin pathway through the miR-18a-5p\/AXIN2\/GSK3beta axis to inhibit the proliferation and migration of bladder cancer cells. Carcinogenesis. 2022;43(12):1176-89.","DOI":"10.1093\/carcin\/bgac087"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Zhu Y, Huang C, Zhang C, Zhou Y, Zhao E, Zhang Y, Pan X, Huang H, Liao W, Wang X. lncRNA MIR200CHG inhibits EMT in gastric cancer by stabilizing miR-200c from target-directed miRNA degradation. Nat Commun. 2023;14(1):8141.","DOI":"10.1038\/s41467-023-43974-w"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Ding Y, Huang Y, Zhang F, Gong L, Liang C, Ding K, He X, Ding X, Chen Y. lncRNA TDRKH-AS1 promotes breast cancer progression via the miR-134-5p\/CREB1 axis. J Transl Med. 2023;21(1):854.","DOI":"10.1186\/s12967-023-04640-3"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Wang H, Ding Y, He Y, Yu Z, Zhou Y, Gong A, Xu M. lncRNA UCA1 promotes pancreatic cancer cell migration by regulating mitochondrial dynamics via the MAPK pathway. Arch Biochem Biophys. 2023;748:109783.","DOI":"10.1016\/j.abb.2023.109783"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Cao Y, Zou Z, Wu X, Li W, Lu Z, Hu J, Yang L. LUCAT1 inhibits ferroptosis in bladder cancer by regulating the mRNA stability of STAT3. Gene. 2024;894:147974.","DOI":"10.1016\/j.gene.2023.147974"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Ma J, Zhao G, Du J, Li J, Lin G, Zhang J. lncRNA FENDRR inhibits gastric cancer cell proliferation and invasion via the miR-421\/SIRT3\/notch-1 axis. Cancer Manag Res. 2021;13:9175-87.","DOI":"10.2147\/CMAR.S329419"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Yang F, Sun S, Yang F. Prognostic and predicted significance of FENDRR in colon and rectum adenocarcinoma. Front Oncol. 2021;11:668595.","DOI":"10.3389\/fonc.2021.668595"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Pan H, Yu T, Sun L, Chai W, Liu X, Yan M. lncRNA FENDRR-mediated tumor suppression and tumor-immune microenvironment changes in non-small cell lung cancer. Transl Cancer Res. 2020;9(6):3946-59.","DOI":"10.21037\/tcr-20-2147"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Hu M, Zhang M, Qi X, Yuan L, Wu Z, Tian Y, Qi A. Silencing the lncRNA EBLN3P improves prognosis in patients with invasive breast cancer by directly targeting miR-144-3p. J Environ Pathol Toxicol Oncol. 2025;44(1): 1-9.","DOI":"10.1615\/JEnvironPatholToxicolOncol.2024053299"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Hong Y, Li Z, Su Y, Pu H, Zhang X. The ceRNA mechanism of lncRNA MEG3\/miR-21-5p\/SPRY2 in cell proliferation and apoptosis in bladder cancer. Crit Rev Eukaryot Gene Expr. 2024;34(1):55-68.","DOI":"10.1615\/CritRevEukaryotGeneExpr.2023048011"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Qian G, Jin X, Zhang L. lncRNA FENDRR upregulation promotes hepatic carcinoma cells apoptosis by targeting miR-362-5p via NPR3 and p38-MAPK pathway. Cancer Biother Radiopharm. 2020;35(9):629-39.","DOI":"10.1089\/cbr.2019.3468"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Liu Y, Yang H. MiR-18a-5p attenuates HER2-positive breast cancer development by regulating PI3K\/AKT pathway. Cancer Biol Ther. 2023;24(1):2224512.","DOI":"10.1080\/15384047.2023.2224512"},{"key":"25","unstructured":"Quan B, Liu W, Yao F, Li M, Tang B, Li J, Ren Z, Yin X. LINC02362\/hsa-miR-18a-5p\/FDX1 axis suppresses proliferation and drives cuproptosis and oxaliplatin sensitivity of hepatocellular carcinoma. Am J Cancer Res. 2023;13(11):5590-609."},{"key":"26","doi-asserted-by":"crossref","unstructured":"Liang B, Zhou C, Cui S, Lu H, Xu R, Xue D, Zou S, He X. Upregulation of miR-18a-5p promotes the proliferation of prostate cancer via inhibiting the expression of SLC40A1. Pathol Res Pract. 2021;224:153448.","DOI":"10.1016\/j.prp.2021.153448"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Wang L, Cui M, Cheng D, Qu F, Yu J, Wei Y, Cheng L, Wu X, Liu X. miR-9-5p facilitates hepatocellular carcinoma cell proliferation, migration and invasion by targeting ESR1. Mol Cell Biochem. 2021;476(2):575-83.","DOI":"10.1007\/s11010-020-03927-z"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Wei B, Lou W. Bioinformatic analysis shows the correlation of hsa_circ_0006220-miR-221\/222-3p-ESR1\/KDR axis with sorafenib resistance of hepatocellular carcinoma. Noncoding RNA Res. 2024;9(1):55-65.","DOI":"10.1016\/j.ncrna.2023.11.001"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Zhang P, Song D, Fang Z, Sun D, Wang L, Shi L, Gao L, Jiang X. Cardamomin inhibits the proliferation and tumorigenesis of bladder cancer by ESR1 in PI3K\/AKT pathway. Biochem Genet. 2025;63(4):2946-66.","DOI":"10.1007\/s10528-024-10854-x"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Li J, Feng S, Wang X, Zhang B, He Q. Exploring the targets and molecular mechanisms of curcumin for the treatment of bladder cancer based on network pharmacology, molecular docking and molecular dynamics. Mol Biotechnol. 2025;67(5):2138-59.","DOI":"10.1007\/s12033-024-01190-x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Ge Q, Lu M, Ju L, Qian K, Wang G, Wu CL, Liu X, Xiao Y, Wang X. miR-4324-RACGAP1-STAT3-ESR1 feedback loop inhibits proliferation and metastasis of bladder cancer. Int J Cancer. 2019;144(12):3043-55.","DOI":"10.1002\/ijc.32036"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Chi M, Liu J, Mei C, Shi Y, Liu N, Jiang X, Liu C, Xue N, Hong H, Xie J, Sun X, Yin B, Meng X, Wang B. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K\/AKT pathway in bladder cancer. J Exp Clin Cancer Res. 2022;41(1):175.","DOI":"10.1186\/s13046-022-02377-3"}],"container-title":["Journal of Environmental Pathology, Toxicology and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dl.begellhouse.com\/download\/article\/2f88bb980c274a41\/JEP(T)-56717.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T17:42:10Z","timestamp":1771004530000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dl.begellhouse.com\/journals\/0ff459a57a4c08d0,2fb6b68a749338cd,2f88bb980c274a41.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1615\/jenvironpatholtoxicoloncol.2025056717","relation":{},"ISSN":["0731-8898"],"issn-type":[{"value":"0731-8898","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}